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Abstract: Across sub-Saharan Africa, key populations with elevated HIV-1 incidence and/or 
prevalence have been identified, but their contribution to disease spread remains unclear. We 
performed viral deep-sequence phylogenetic analyses to quantify transmission dynamics between 
the general population (GP), fisherfolk communities (FF), and women at high risk of infection and 
their clients (WHR) in central and southwestern Uganda. Between August 2014 and August 2017, 
6185 HIV-1 positive individuals were enrolled in 3 GP and 10 FF communities, 3 WHR enrollment 
sites. A total of 2531 antiretroviral therapy (ART) naïve participants with plasma viral load >1000 
copies/mL were deep-sequenced. One hundred and twenty-three transmission networks were 
reconstructed, including 105 phylogenetically highly supported source–recipient pairs. Only one 
pair involved a WHR and male participant, suggesting that improved population sampling is 
needed to assess empirically the role of WHR to the transmission dynamics. More transmissions 
were observed from the GP communities to FF communities than vice versa, with an estimated flow 
ratio of 1.56 (95% CrI 0.68–3.72), indicating that fishing communities on Lake Victoria are not a net 
source of transmission flow to neighboring communities further inland. Men contributed 
disproportionally to HIV-1 transmission flow regardless of age, suggesting that prevention efforts 
need to better aid men to engage with and stay in care. 
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1. Introduction 
In 2019, the Joint United Nations program on HIV/AIDS (UNAIDS) reported an estimated 1.4 
million people that were living with HIV-1 in Uganda [1]. Despite significant decreases in HIV-1 
prevalence and incidence since the early 1990s, the epidemic in Uganda remains self-sustaining 
through heterosexual transmission in the general population (GP) [2]. Certain key populations in 
Uganda are particularly affected by HIV-1. These include fisherfolk (FF), women at high risk of HIV-
1 infection (WHR), men who have sex with men, injection drug users, as well as men and women of 
the uniformed forces [3]. Average national HIV-1 incidence is estimated at less than 1 per 100 person 
years at risk (1/100 PYAR) [4], while incidence rates among FF and WHR are respectively estimated 
at 6/100 PYAR [5] and 3/100 PYAR [6]. Individuals in these groups also have a higher tendency to 
engage in high-risk sexual behavior, which led to the hypothesis that they may drive HIV-1 
transmission in general, and sustain transmission in the GP [2,7]. 
UNAIDS and the WHO have recommended that countries develop combination HIV-1 
intervention packages that are tailored to their high-risk/key populations in order to curb the HIV-1 
epidemic in a cost-effective manner [8,9]. To achieve this, several strategies have been suggested. 
These include spatial mapping to identify geographic areas of higher-than-average HIV-1 prevalence 
[10] and demographic surveillance to characterize populations that are at higher risk of HIV-1 
infection [11,12]. Recent studies in Uganda have employed spatial mapping and demographic 
surveillance prior to the implementation of combination interventions in high-risk populations like 
FF [13,14] and WHR [15]. In addition, phylogenetic analyses have been increasingly used to 
characterize aspects of HIV-1 transmission dynamics from nucleotide sequences of the virus. For 
instance, phylogenetic analysis helped to reconstruct the historical spread of HIV-1 [16–18], 
characterize HIV-1 transmission networks [19,20], identify traits associated with onward viral 
transmission in high-risk groups [21,22], and evaluate HIV-1 migration patterns [23,24]. In 
combination with sociodemographic or epidemiological data, these approaches have provided useful 
insights in assessing risk factors associated with HIV-1 spread [25] and identifying micro-epidemics 
[26], thus informing prevention strategies. Furthermore, they have been applied in source-attribution 
studies to assess the role of viral introductions from other communities [27,28], and to identify 
populations that serve as sinks or sources for HIV-1 transmission [29,30]. In particular, we previously 
estimated that high-prevalence FF communities located in central and southwestern Uganda are net 
recipients (sinks) of local HIV-1 transmission flow, based on phylogeographic analysis of 208 subtype 
A and 177 subtype D consensus sequences [29]. A second analysis estimated that there were 2.50 
times (95% credibility interval (95%CrI) 1.02–7.30) more transmissions from inland to fishing areas 
than vice versa, based on a sample of 2652 viral deep-sequences and after accounting for human 
migration dynamics [30]. The two studies thus showed that the relatively small FF communities 
around Lake Victoria are not driving the surrounding HIV-1 epidemics regardless of their high HIV-
1 prevalence. 
Here, we test the finding that FF communities are net sinks and not sources of local transmission 
flow on an independent data set that includes a larger set of fishing villages. In addition, we aim to 
assess the extent to which key populations (FF and WHR) and socio-demographic factors contribute 
to the HIV-1 epidemic in the GP. To this end, the Medical Research Council/Uganda Virus Research 
Institute and London School of Hygiene & Tropical Medicine (MRC/UVRI and LSHTM) Uganda 
Research Unit team enrolled HIV-1 infected individuals in fishing villages along the shores of Lake 
Victoria, neighboring inland areas (approximately 10–40 km) and hotspots of women engaged in 
high-risk sexual behavior (see Figure 1 under Materials and Methods). The PANGEA (Phylogenetics 
And Networks for Generalized Epidemics in Africa) consortium [31] generated HIV-1 deep-
sequences from this convenience sample of infected individuals. The deep-sequence data was then 
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used to reconstruct viral phylogenetic transmission networks that contained information on the 
direction of transmission. Pairs with phylogenetically highly supported evidence for the direction of 
transmission were identified in the networks, and these pairs were used to quantify HIV-1 
transmission flows between the GP, FF, and WHR populations. In doing so, this study also 
demonstrates that HIV deep-sequence data can now be routinely used to reconstruct HIV-1 
transmission networks, and provide important information on the direction of transmission within 
them. 
2. Materials and Methods 
2.1. Study Design and Population 
The MRC/UVRI and LSHTM Uganda Research Unit (MRC) conducted several population-based 
cross-sectional surveys in HIV-1 high-risk and general population groups in central and 
southwestern Uganda [29,32–36]. In this analysis, we combined data collected from several 
populations surveyed between August 2014 and August 2017. Figure 1 below shows a map of the 
study sites. 
 
Figure 1. Map showing the sampling sites. Sites 1 to 10 show the fisherfolk (FF) communities and sites 
A to C show areas where women at high risk of HIV-1 infection (WHR) and some of their clients were 
enrolled. Locations 1 to 6 show areas in the general population (GP) where study participants were 
enrolled. Almost half (40.9%) of HIV-1 positive participants enrolled in clinics and study sites (see 
Table 1) shown on the map in south central Uganda had their samples deep sequenced and subjected 
to phylogenetic analyses. 
The FF study population included individuals from 10 FF communities [13,19,37–39] as shown 
in Figure 1. Individuals were approached in community health facilities (CHF) or during voluntary 
counselling and testing (VCT) campaigns, and were eligible to participate if they had an HIV-1 
positive status and were at least 18 years old (FF communities 1–8) or 14 years (FF communities 9–
10).  
The WHR study population included participants of the MRC Good Health for Women’s Project 
(GHWP), and an extension of this study population to other commercial sex work areas (non-GHWP). 
The GHWP cohort was initiated in 2008, when initially 1027 women were recruited with the objective 
of studying the size, determinants, and dynamics of the HIV-1 epidemic, and remains an open cohort 
with approximately 3000 women enrolled to-date [6,40]. Women above 18 years of age who reported 
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being involved in commercial sex work and/or high-risk sexual behavior, and their clients who 
consented to participate were enrolled in the study. Data were collected on socio-demographic 
characteristics and risk behavior, and consenting participants were tested for HIV-1. 
The GP study population included individuals from rural communities surveyed through the 
MRC General Population Cohort (GPC) since 1989 [33,41]. We additionally sampled areas that 
neighbor the FF populations, as well as areas that are geographically close to the WHR recruitment 
area. In these communities, individuals were recruited in CHF or during VCT campaigns, and eligible 
if they were HIV-1 positive and were at least 16 years old. Further, individuals with HIV-1 infection 
who received care or were diagnosed through VCT were invited to participate. Participants 
completed structured questionnaires that captured general demographic, socioeconomic, marital, 
partnership histories and behavioral data. A biometric fingerprint-scanning device was used on all 
study participants to avoid duplicate enrolments [42]. 
2.3. Ethics Statement 
This study was part of the MRC HIV-1 Molecular Epidemiology study which was approved by 
the Uganda Virus Research Institute Research and Ethics Committee (UVRI-REC) on the 24th/06/2013 
(Federal Wide Assurance (FWA) No. 00001354, Project identification code: GC/127/13/06/27) and the 
Uganda National Council for Science and Technology (UNCST) on the 12th/09/2013 (FWA No. 
00001293, Project identification code: HS 1432). All participants were recruited voluntarily and 
provided written informed consent.  
2.4. Deep Sequencing and Assembly of HIV-1 Reads 
First, 10 mL of blood was collected from the study participants by venipuncture, including those 
on antiretroviral therapy (ART). Next generation sequencing was performed on samples from 
infected participants who did not report ART use and who had sufficient plasma viraemia (viral load 
>1000 copies/mL). HIV-1 deep sequencing was performed using the Illumina Miseq platform at the 
Africa Health Research Institute (Durban, South Africa), and at the Wellcome Trust Sanger Institute 
(Hinxton, UK) [43,44]. Briefly, viral RNA was extracted from plasma samples using the QIAamp Viral 
RNA Minikit (Qiagen Inc., Valencia, CA, USA). Reverse transcription and amplification of the 
extracted viral RNA was done in a one-step RT-PCR reaction using a set of 4 HIV-1 primers that were 
designed for the amplification of HIV-1 genomes in four overlapping amplicons for all groups and 
subtypes [43]. Amplicons were pooled in equimolar quantities according to the manufacturer’s 
instructions for the library preparation step using the Nextera XT kit. Library validation was 
performed using the Agilent Bioanalyzer before sequencing was done using the Miseq 250-bp paired 
end technology as previously described [43]. Deep-sequencing reads were assembled using the 
Shiver pipeline [45].  
2.5. Deep-Sequence Phylogenetic Analysis 
We used phyloscanner version 1.8.0 to reconstruct directed HIV-1 transmission networks from 
deep sequences [46]. Briefly, phyloscanner analysis starts with HIV deep-sequence reads from a set 
of infected individuals that are mapped against reference sequences of the entire genome. Across the 
genome, sliding windows are defined, and for each window, paired-end reads from all individuals 
that overlap the window are extracted and aligned, and deep-sequence phylogenies reconstructed. 
In our analysis, windows were of length 250 bp and incremented by 25 bp across the entire genome. 
Next, viral lineages in the deep-sequence phylogenies were attributed to each individual using 
maximum parsimony ancestral state reconstruction, which defined larger parts (called “subgraphs”) 
of the deep-sequence phylogenies that are attributed to viral evolution within each individual. Using 
Sanger sequencing, typically one sequence is available per person, and in this case, each subgraph 
consists of the tip sequence only that corresponds to the sampled individual. Using deep-sequence 
data, subgraphs of each individual typically comprise several tips and inner nodes in the phylogeny, 
and this information can be used to characterize the relationship of individuals in terms of distance 
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between subgraphs and topological relationship between subgraphs. Figure 2 shows the subgraph 
distances (y-axis) and subgraph topologies (color) between a pair of individuals in the phylogenies 
that were reconstructed from the overlapping 250 bp read alignments across the genome. The 
subgraph distances are used to infer phylogenetic linkage, and the subgraph topologies are used to 
infer the likely direction of transmission between individuals (Figure 2b). A phyloscanner analysis 
returns for each pair of individuals phylogenetic scores for linkage and transmission direction that 
are calculated across all genomic windows [46–48]. The scores indicate the proportion of genomic 
windows with phylogenetic support for linkage and transmission direction, after accounting for 
overlap between the read alignments. 
2.6. Reconstruction of Transmission Networks 
To reconstruct phylogenetic transmission networks, we first determined the deep-sequence 
phylogenetic relationships between all possible pairs of individuals in the sample with phyloscanner. 
Analysis proceeded in batches of 75 individuals, which considerably reduced the number of deep-
sequence phylogenies that had to be estimated, and computational burden [47]. Second, from this 
output we identified pairs of individuals between whom phylogenetic linkage could not be excluded 
based on subgraph distance in deep-sequence phylogenies. Third, potentially phylogenetically linked 
pairs of individuals were grouped into larger phylogenetic transmission networks so that each 
individual was linked to at least one other individual. Fourth, each potential transmission network 
was separately analyzed with phyloscanner to substantiate membership of individuals in networks, 
and to estimate the phylogenetically likely direction of viral spread within networks. Fifth, we 
considered all possible transmission chains in these networks, which corresponded to all possible  
minimum (directed) spanning trees, similar as in [49,50]. We then identified the most likely 
transmission chain as the minimum spanning tree that maximized the product of phyloscanner 
transmission scores in the directions of the edges in the spanning tree [47]. Sixth, we extracted pairs 
of individuals with strong support for phylogenetic linkage and strong support for the direction of 
transmission in the phylogenetically most likely transmission chain (source–recipient pairs), using a 
threshold of 0.6 on the phyloscanner scores (see [47] for a justification of the threshold). The analysis 
protocol and phyloscanner runtime arguments were exactly as described in [47]. This analysis in 
general cannot rule out the presence of unsampled intermediates in the phylogenetically most likely 
transmission chains, and among source–recipient pairs. 
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Figure 2. (A) Phyloscan plot showing deep-sequence phylogenies reconstructed at 250 bp genomic 
window intervals across the genome. Ancestral state reconstruction was used to attribute 
phylogenetic lineages to individuals, and phylogenetic subgraphs were defined as groups of lineages 
that were attributed to the same individual. For a pair of individuals, the scan plots show the shortest 
patristic distance between subgraphs of both individuals (y-axis) and the topological relationship 
between subgraphs of both individuals (colors) across the genome (ancestral to one another (light 
blue), siblings (yellow), intermingled (dark blue), or disconnected (purple)). (B) Description of 
topological relationship between subgraphs in deep-sequence phylogenies. The phylogenetic 
topology or ordering of subgraphs is used to infer the likely direction of transmission between 
individuals [48]. Ancestral 1->2 means that at least one subgraph from individual 1 is phylogenetically 
adjacent to a subgraph from individual 2, and that all adjacent subgraphs from individual 1 are 
ancestral to those of individual 2. This phylogenetic pattern is consistent with transmission from 
individual 1 to individual 2, possibly via unsampled intermediates. Similarly, ancestral 2->1 means at 
least one subgraph from individual 1 is phylogenetically adjacent to a subgraph from individual 2, 
and that all adjacent subgraphs from individual 1 are descendent from those of individual 2. This 
phylogenetic pattern is consistent with transmission from individual 2 to individual 1, possibly via 
unsampled intermediates. Intermingled 1~2 means that at least one subgraph from individual 1 is 
phylogenetically adjacent to one subgraph from individual 2, and that there are adjacent subgraphs 
from individual 1 ancestral to those of individual 2, and vice versa. Sibling 1~2 means that at least one 
subgraph from individual 1 is phylogenetically adjacent to one subgraph from individual 2, and that 
the adjacent subgraphs are phylogenetically next to each other. These two patterns indicate that the 
two individuals are closely related, but there is no evidence for the direction of transmission. 
Disconnected refers to individuals who have subgraphs that are not adjacent to each other. This 
pattern suggests that the two individuals are phylogenetically unlinked. 
2.6. Quantifying HIV-1 Transmission Flows 
We used the phyloflows package, version 1.1.0, implemented in the R software [51] to quantify 
HIV-1 transmission flows within and between the three populations, while adjusting for sampling 
heterogeneity across our study populations. Briefly, a Bayesian model was used to estimate 
transmission flows in population groups under the assumption that each group was sampled at 
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random, but with potentially different sampling rates [30]. A Markov Chain Monte Carlo (MCMC) 
algorithm was used to obtain samples from the posterior distribution of transmission flows, was run 
for 50,000 iterations, and the initial 5% were discarded as burn-in. Convergence was assessed with 
the Gelman–Rubin statistic [52], and all effective sample sizes of the marginal posterior transmission 
flows were well above 1000. Examplary MCMC outputs are shown in Supplementary Figure S1. 
3. Results 
3.1. Population-Based Sample of HIV-1 Deep Sequences 
Between August 2014 and August 2017, a total of 6185 HIV-1 positive individuals were enrolled 
in CHF and VCT campaigns, of whom 2531 were deep-sequenced (at a sequencing depth of >30× over 
at least 5000 nt of the HIV-1 genome). A total of 3200 participants were from the GP of whom 1578 
were male and 1622 female. Then, 1309 (40.9%) samples were deep-sequenced, comprising 636 men 
(40.3% of 1578) and 673 women (41.5% of 1622). Further, 2185 participants were from fishing sites of 
whom 1103 were male and 1082 were female. Then, 895 (41.0%) samples were deep-sequenced, 
comprising 468 men (42.4% of 1103) and 427 (39.5% of 1082) women. There were 720 women at high 
risk and 80 male clients recruited, of whom 301 (41.8%) women at high risk and 26 (32.5%) clients 
were deep-sequenced. Table 1 provides further demographic information on the recruited and 
sampled individuals. The proportion of men and women who had their samples deep sequenced in 
each study population were similar, with the exception of male clients of women at high risk. 
Table 1. Study population, and proportion of sampled and sequenced individuals. 
Population and gender 
HIV-positive 
participants 
Deep 
sequenced 
Proportion of HIV-positive 
participants who were sequenced 
Total  6185 2531 40.9% 
Fisherfolk  2185 895 41.0% 
Men 1103 (50.5%) 468 (52.3%) 42.5% 
Women 1082 (49.5%) 427 (47.7%) 39.5% 
General population  3200 1309 40.9% 
Men 1578 (49.3%) 636 (48.6%) 40.3% 
women 1622 (50.7%) 673 (51.4%) 41.5% 
Women at high risk and 
male clients 
800 327 40.9% 
Men 80 (10.0%) 26 (8.0%) 32.5% 
Women 720 (90.0%) 301 (92.0%) 41.8% 
3.2. Reconstructed HIV-1 Transmission Networks 
A total of 123 HIV-1 transmission networks were reconstructed with phyloscanner, of which 101 
(82.1%) comprised of 2 individuals, 20 (16.3%) comprised of 3–5 individuals, 0 comprised 6–10 
individuals, and 2 (1.6%) comprised of >10 individuals (Figure 3a). In larger networks, pairs of 
individuals between whom linkage was not excluded had larger subgraph distances (median 
distances were 0.5% in networks of size 2, 0.6% in networks of size 3–5, and 2.1% in networks of size 
>10; see Table S1), suggesting that in larger networks, slightly more phylogenetic distant individuals 
were connected. In the reconstructed transmission networks, a total of 105 source–recipient pairs with 
strong support for phylogenetic linkage and direction of transmission were identified based on the 
criteria described under methods. Further analysis was restricted to these highly supported source–
recipient pairs. Figure 3b illustrates one of the largest identified networks. In the figure, source–
recipient pairs are highlighted with arrows in black. No arrows were drawn when the corresponding 
two individuals were classified as phylogenetically unlinked in at least 60% of deep-sequence 
phylogenies across the genome. 
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Figure 3. (a) Cluster size distribution of HIV-1 transmission networks. The cluster size distribution of 
transmission networks consisted of 101 sequences that were linked as pairs, 15 clusters of 3 linked 
sequences, 4 clusters of 4 linked sequences, 1 cluster of 5 linked sequences, 1 cluster of 11 linked 
sequences and 1 cluster of 15 linked sequences. (b) Transmission pairs with phylogenetic evidence 
for the direction of HIV-1 transmission. The blue colored circles represent sequences that are linked 
to one another with phyloscanner scores (%) showing support for transmission in either direction 
between individual sequences. Source–recipient pairs that had phyloscanner scores >60% for linkage 
and >60% for one direction were considered highly supported. 
3.3. HIV-1 Transmission within and between Study Participants of the General Population, Fisherfolk, and 
the Women at High Risk Cohort and their Clients. 
The phylogenetically reconstructed networks included 105 source–recipient pairs (Table 2, 
column three). The majority of reconstructed source–recipient pairs were within the population 
groupings. Thirty-six (34.3%) were from GP to GP; 33 (31.4%) were from FF to FF, and 10 (9.5%) were 
from WHR to WHR. Between population groups, we found 14 (13.3%) source–recipient pairs from 
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GP to FF, 9 (8.6%) pairs from the FF to the GP, 2 (1.9%) pairs from FF to WHR, and 1 pair (1.0%) from 
WHR to the GP.  
Considering gender, 50 (47.6%) source–recipient pairs were male to female, 12 (11.4%) were male 
to male, 24 (22.9%) were female to male, 10 (9.5%) were female to female among WHR, and 9 (8.6%) 
were female to female and involved at most one WHR (Supplementary Table S2). Observing male–
male pairs was not significantly more likely than observing female–female pairs outside WHR. Thus, 
the most likely explanation for the presence of phylogenetically linked same-sex pairs is that 
intermediate individuals or common source cases of the opposite gender remained unsampled. In 
particular, there was only 1 male–female pair among the 13 highly supported source–recipient pairs 
that involved WHR, suggesting that a substantial number of WHR male clients were not captured in 
our populations. Due to this under-sampling of male clients, pairs from the WHR population were 
excluded from the subsequent HIV-1 transmission flow analysis. Column four in Table 2 lists the 
phylogenetically reconstructed source–recipient pairs after excluding same-sex pairs.  
We estimated HIV-1 transmission flows within and between the FF and GP study participants, 
while accounting for slightly different sequence sampling fractions of HIV-1 positive participants. 
Overall, transmission was assortative within the FF and GP participants, with an estimated 
assortativity coefficient of 0.32 (95% CrI 0.10–0.53). More specifically, the estimated transmission 
flows when same-sex pairs were included are listed in Table 2 column five, and the estimated 
transmission flows when same-sex pairs were excluded are listed in Table 2 column six. Within and 
between groups of study participants, the estimated HIV-1 transmission flows were 45.5% (95% 
credibility interval (CrI) 34.1%–57.0%) from FF to FF, 12.7% (95% CrI 6.1%–21.3%) from FF to GP, 
19.5% (95% CrI 11.4%–29.3%) from GP to FF, and 22.3% (95% CrI 13.4%–32.7%) from GP to GP in the 
analysis excluding same-sex pairs. The estimated flows were significantly different when same-sex 
pairs were excluded, because 20 (95.2%) of 21 same-sex source–recipient pairs were within the GP. 
All phylogenetically reconstructed transmissions between GP and FF locations involved a male and 
a female, and so there were more transmissions from GP to FF locations compared to the opposite 
direction regardless of excluding same-sex source–recipient pairs. The estimated flow ratio of 
transmission flows from GP to FF divided by flows from FF to GP was 1.56 (95% CrI 0.68–3.72). 
We next estimated the sources of HIV-1 acquisition among the FF and GP study participants 
after adjusting for sequence sampling differences (Table 3). For any HIV-1 infection found in the FF 
sample, the probability that it originated from other FF was 70.4% (95% CrI 56.2%–81.9%), and the 
probability that it originated from the GP was 29.6% (95% CrI 18.1%–43.8%) when same-sex pairs 
were excluded. For any HIV-1 infection found in the GP sample, the probability that it originated 
from the GP was 80.2% (95% CrI 66.8%–90.0%), and the probability that it originated from the FF was 
19.8% (95% CrI 10.0%–33.2%) when same-sex pairs were excluded.  
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Table 2. Phylogenetically observed HIV-1 transmission flows. 
Sources  Recipients  
Phylogenetically 
strongly supported 
transmission pairs 
including same-sex 
pairs *  
(count, proportion) 
Phylogenetically 
strongly supported 
transmission pairs 
excluding same-sex pairs 
*  
(count, proportion) 
Estimated transmission flows 
among study participants, 
based on data including same-
sex pairs **  
(mean, 95% credibility interval 
of posterior density) 
Estimated transmission flows 
among study participants, 
based on data excluding same-
sex pairs **  
(mean, 95% credibility interval 
of posterior density) 
Estimated transmission 
flow ratios, based on data 
excluding same-sex pairs*** 
(mean, 95% credibility 
interval of posterior 
density) 
FF FF 33 (31.4%) 33 (44.6%) 35.8% (26.2%–46.1%) 45.5% (34.1%–57.0%) -- 
FF GP 9 (8.6%) 9 (12.1%) 9.9% (4.7%–16.8%) 12.7% (6.1%–21.3%) -- 
FF WHR 2 (1.9%) 1 (1.4%) -- -- -- 
GP FF 14 (13.3%) 14 (18.9%) 15.3% (8.7%–23.3%) 19.5% (11.4%–29.3%) 1.56 (0.68–3.72) 
GP GP 36 (34.3%) 16 (21.6%) 39.0% (29.0%–49.4%) 22.3% (13.4%–32.7%) -- 
WHR GP 1 (1.0%) 1 (1.4%) -- -- -- 
WHR WHR 10 (9.5%) 0 (0%) -- -- -- 
* Phylogenetically reconstructed transmission events, unadjusted for sequence sampling differences across populations. ** Estimates were obtained with the phyloflows 
source attribution model, are based on the number of phylogenetically reconstructed events, and are adjusted for sequence sampling differences across populations. Flows 
from and to WHR were not estimated due to under-sampling of WHR clients, see main text. *** Estimated flow ratios were GP->FF / FF->GP. 
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Table 3. Phylogenetically estimated sources of HIV-1 acquisition among FF and GP study 
participants. 
 
Estimated sources of infection among study participants, based on data excluding same-sex 
pairs* (mean, 95% credibility interval of posterior density) 
 FF GP 
Recipient   
FF 70.4% (56.2%–81.9%) 29.6 (18.1%–43.8%) 
GP 19.8% (10.0%–33.2%) 80.2% (66.8%–90.0%) 
* Estimated transmission probabilities from a source to recipient location; shown are the mean and 
corresponding 95% credibility interval of posterior density. 
3.4. HIV Transmission by Gender 
After excluding same-sex pairs and accounting for differences in sequence sampling fractions of 
men and women, an estimated 68.0% (56.6%–78.1%) of transmissions in the sample originated from 
men and 32.0% (21.9%–43.4%) from women. 
3.5. HIV-1 Transmission by Age Groups 
We further characterized the age-specific HIV-1 transmission flows among the phylogenetically 
highly supported source–recipient pairs (Table 4). We sought to use the same age band as in de 
Oliveira et al. [25] to enable a comparison between the population sampled in KwaZulu-Natal, South 
Africa, and our settings in central and southwestern Uganda. However, with 74 reconstructed 
source–recipient pairs between men and women, we reduced these further to age bands 18–24 years 
and 25–59 years at time of diagnosis. In the sample, transmission was not assortative within the two 
age groups in both the male-to-female and female-to-male direction, with estimated assortativity 
coefficients of 0.07 (95% CrI −0.18–0.33) and −0.08 (−0.40–0.28) respectively. More detailed analysis of 
the transmission flows showed that most (n = 18, 25.0%) phylogenetically reconstructed transmissions 
occurred from men of 25–59 years to women of 25–59 years, followed by transmissions (n = 13, 18.1%) 
from men of 25–59 years to women of 18–24 years. The estimated transmission flows among 
participants after adjusting for sequence sampling differences are reported in Table 4 column 4. 
Considering transmission flows from men to women compared to vice versa, the estimated flow 
ratios were 3.16 (95% CrI 0.92–14.44) from men aged 18–24 years to women aged 18–24 years 
compared to vice versa, 1.29 (95% CrI 0.47–3.69) from men aged 18–24 years compared to vice versa, 
2.63 (95% CrI 0.96–8.28) from men aged 25–59 compared to vice versa, and 2.29 (95% CrI 1.02–5.52) 
from men aged 25–59 to women aged 25–59 compared to vice versa.  
We also estimated the sources of infection among women aged 18–24 years and women aged 
25–59 years in our sample, and similarly for men (Table 5). Considering women aged 18–24 years in 
the sample, an estimated 34.7% (17.1%–55.9%) of infections originated from men aged 18–24 years, 
and 65.3% (95% CrI 44.1%–82.9%) of infections originated from men aged 25–59 years. Considering 
women aged 25–59 years in the sample, an estimated 27.7% (14.1%–45.7%) of infections originated 
from men aged 18–24 years, and 72.3% (54.3%–85.9%) of infections originated from men aged 25–59 
years. Considering men aged 18–24 years in the sample, an estimated 24.2% (6.3%–54.0%) of 
infections originated from women aged 18–24 years, and 75.8% (46.0%–93.7%) of infections 
originated from women aged 25–59 years. Considering men aged 25–59 years in the sample, an 
estimated 32.6% (12.7%–59.9%) of infections originated from women aged 18–24 years, and 67.4% 
(40.1%–87.3%) of infections originated from women aged 25–59 years. 
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Table 4. Phylogenetically estimated transmission flows by age. 
  
Phylogenetically strongly supported transmission 
pairs excluding same-sex pairs *   
(count, proportion) 
Estimated transmission flows among study participants, 
based on data excluding same-sex pairs** 
(mean, 95% credibility interval of posterior density) 
Estimated transmission flow ratios, based on 
data excluding same-sex pairs*** 
(mean, 95% credibility interval of posterior 
density) 
Source Recipient    
Men 18–24 
years 
Women 18–24 
years 
9 (12.5%) 9.1% (4.2%–15.7%) 3.16 (0.92–14.44) 
Men 18–24 
years 
Women 25–59 
years 
9 (12.5%) 11.7% (5.6%–19.9%) 1.29 (0.47–3.69) 
Men 25–59 
years 
Women 18–24 
years 
13 (18.1 %) 17.0% (9.2%–26.3%) 2.63 (0.96–8.28) 
Men 25–59 
years 
Women 25–59 
years 
18 (25%) 29.8% (19.2%–41.7%) 2.29 (1.02–5.52) 
Women 18–
24 years 
Men 18–24 
years 
3 (4.2%) 3.1% (0.7%–7.5%) -- 
Women 18–
24 years 
Men 25–59 
years 
5 (6.9%) 6.7% (2.3%–13.4%) -- 
Women 25–
59 years 
Men 18–24 
years 
7 (9.7%) 9.2% (3.8%–16.8%) -- 
Women 25–
59 years 
Men 25–59 
years 
8 (11.1%) 13.4% (6.1%–22.9%) -- 
* Phylogenetically reconstructed transmission events, unadjusted for sequence sampling differences across sampling groups. ** Estimated transmission probabilities from 
a source to recipient group in the sample; shown are the mean and corresponding 95% credibility interval of posterior density. *** Estimated flow ratios were respectively 
M18–24->F18–24 / F18–24->M18–24 and M25–59->F18–24 / F18–24->M25–59. 
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Table 5. Phylogenetically estimated sources of HIV-1 acquisition among male and female study 
participants by age. 
 
Estimated sources of infection among study participants, based on data excluding same-sex 
pairs* (mean, 95% credibility interval of posterior density) 
 Men 18–24 years Men 25–59 years Women 18–24 years Women 25–59 years 
Recipient     
Women 18–24 
years 
34.7% (17.1%–55.9% 65.3% (44.1%–82.9%) -- -- 
Women 25–59 
years 
27.7% (14.1%–45.7%) 72.3% (54.3%–85.9%) -- -- 
Men 18–24 
years 
-- -- 24.2% (6.3%–54.0%) 75.8% (46.0%–93.7%) 
Men 25–59 
years 
-- -- 32.6% (12.7%–59.9%) 67.4% (40.1%–87.3%) 
Estimated transmission probabilities from a source to recipient location; shown are the mean and 
corresponding 95% credibility interval of posterior density. Rows sum to 100%. 
4. Discussion 
In this study, we reconstructed phylogenetic transmission networks from HIV-1 deep sequences 
in a large convenience sample of HIV-1 infected individuals from high-risk and general population 
groups in central and southwestern Uganda. Based on the reconstructed transmission networks, we 
estimated HIV-1 transmission flows within and between distinct populations (GP, FF, and WHR) in 
our sample, and by gender and age. We also estimated the sources of HIV-1 infection in these 
population groups. Several molecular epidemiology studies have used nucleotide sequence data 
generated by Sanger sequencing to characterize HIV-1 transmission dynamics in FF communities 
[19,53] and other high-risk groups [23]. Here, we were able to infer directed HIV-1 transmission 
networks through viral phylogenetic analysis, because deep-sequencing output generated multiple 
sequence reads from each sampled individual, from which the direction of transmission could be 
inferred at an accuracy sufficient for population-level analyses [46,48]. We estimated a higher 
proportion of HIV-1 transmissions among participants from the FF (45.5% (34.1%–57.0%) compared 
to participants from the GP (22.3% (13.4%–32.7%) after adjusting for heterogeneity in the proportion 
of participants that were sequenced. These estimates do not necessarily imply that a larger proportion 
of transmissions occur in FF populations compared to GP populations, because the fraction of the FF 
populations surveyed was larger than the fraction of the GP populations surveyed. However, 
sampling fractions cancel out in the flow ratio statistics. Specifically, if    
   denotes the true 
transmission flows from population group   to population group   and    
   the transmission flows 
among recruited individuals of groups   and  , then: 
   
 
   
  =
  
   
    
 
  
   
    
  =
   
 
   
  , 
where   
  denotes the probability of recruiting an infected individual from population group   into 
the convenience sample. This equation assumes that individuals were equally likely to be recruited 
whether they were a source of further infections or not. Thus, the flow ratios that we inferred in our 
convenience sample can be interpreted as estimates of the corresponding population flow ratios. We 
found that the flow ratio of transmissions from GP to FF compared to vice versa was 1.56 (95% CrI 
(0.68–3.72). Although not statistically significant, our inferences provide further evidence that high-
prevalence fishing communities along Lake Victoria are a sink and not a source of the local epidemic 
[29,30]. 
We found a substantial number of viral introductions into FF communities. Considering that 
participants were disproportionally recruited in FF populations, we expect that the estimated 
proportion of GP infections in the sample attributable to GP sources (80.2%) is a lower bound of the 
proportion of infections in the GP population that is attributable to GP sources. Similarly, we expect 
Viruses 2020, 12, 331 14 of 21 
 
that the estimated proportion of FF infections in the sample attributable to FF sources (70.4%) is an 
upper bound of the proportion of infections in the FF population that is attributable to FF sources. In 
a study done in Rakai [30], differences in survey sampling were adjusted for, and the estimated 
proportion of FF infections attributable to FF sources was 54.8% (95% CrI 42.2%–69.0%). Thus, taken 
together, the two studies indicate very high levels of viral introductions to the HIV-1 epidemic in FF 
populations for the duration of both studies, from August 2011 to August 2017. 
HIV-1 transmission in the GP and across populations into the FF communities was mostly driven 
by individuals above 25 years of age relative to those younger than 25 years. We found that an 
estimated 65.3% (44.1%–82.9%) of women aged 18–24 years in the sample were infected by men above 
25 years, consistent with findings from a recent study conducted in South Africa [25]. However, we 
also found that an estimated 75.8% (46.0%–93.7%) of men aged 18–24 years in the sample were 
infected by women above 25 years. There was no combination of age groups in which transmissions 
from women to men outweighed those from men to women, suggesting that women in the sample 
are “sinks” of HIV-1 transmission regardless of age. These observations challenge the concept of a 
transmission cycle wherein young women are infected by older men, and then transmit to men of 
similar age [25]. 
This study has limitations. First, individuals were recruited in health care facilities and during 
VCT campaigns, and so this study did not include infected individuals who had not yet linked to 
care. Second, our convenience sample preferentially included infected individuals from FF 
populations, rendering it challenging to extrapolate transmission flow estimates from study 
participants to the population the participants were recruited from. However, the flow ratio statistics 
in Tables 2 and 4 are invariant to differential sampling of population groups, and can thus be used to 
characterize population-level HIV-1 spread. Third, few WHR male clients were recruited, and we 
were not able to substantiate the transmission probabilities from this population as a source of 
infections. Recruitment of male clients and partners of WHR in the parent study was challenging due 
to stigma or other unknown socio-behavioral factors that the men in this group associated with study 
participation. We observed from our socio-demographic data that WHR were a mobile group of 
individuals who interacted with high-risk male individuals in the GP and FF particularly during peak 
seasons of high fish stock, suggesting that a non-negligible proportion of infections may originate 
from WHR. Fourth, virus from less than 50% of enrolled participants could be deep-sequenced, 
excluding those that did not have sufficient viraemia for HIV-1 nucleic acid amplification and deep 
sequencing. Our sample comprised study participants who were ART naïve or on therapy with 
unsuppressed virus, and it is possible that transmissions from individuals who reached viral 
suppression soon after infection are under-represented in our data. Generation of additional HIV-1 
deep sequence data based on sequencing protocols that amplify proviral HIV-1 DNA or sequence 
virus from low viraemic specimens [54,55] is a consideration for our future analyses. Fifth, 
transmissions including individuals with co-infections may have been excluded by the definition of 
source–recipient pairs. It is important to note that while the FF communities investigated in this study 
were net recipients for viral transmission (sinks) from GP population groups, the possibility of fishing 
villages being sources of HIV-1 transmission to other populations cannot be ruled out. 
Phylogenetic reconstruction of HIV transmission networks is increasingly common to 
characterize HIV dynamics, typically based on tools such as HIV-TRACE [56] or Cluster Picker [57]. 
These tools can be applied to Sanger sequence data, and the reconstructed networks represent sets of 
phylogenetically linked individuals whose viral genetic relatedness suggest a direct or indirect 
epidemiologic link. In contrast, the deep-sequence approach adopted here provides further 
information into the direction of transmission between individuals in such networks using additional 
signal in the topology of deep-sequence phylogenetic trees. However, while the deep-sequence 
approach is advantageous in several aspects, there are important potential limitations to consider in 
future applications. Most obviously, deep-sequence phylogenetic analyses require deep-sequence 
data, which is only beginning to become more broadly available [31,58,59]. It is also important to 
consider the substantially larger requirements on storage (on the order of hundreds of gigabytes for 
our population-based study), as well as analysis time (~300 phylogenies reconstructed for each 
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potential transmission network across sliding windows of the entire HIV genome is computationally 
intensive). Finally, due to the complexity involved in handling deep-sequence data, available analysis 
software does not easily install on Windows systems [46,60]. However, these challenges are primarily 
of logistic nature and we see no fundamental reason that prevents use of HIV deep-sequence 
technology to support the End the HIV initiative in the US as well as similar efforts [61,62].  
In conclusion, the reconstructed patterns of HIV-1 transmission found across cohorts of HIV-1 
infected individuals in central and southwestern Uganda support previous findings [29,30] that high-
prevalence fishing communities on Lake Victoria are net recipients of HIV-1 transmission flow in the 
local epidemic, and not a net source of transmission flow to the neighboring low-prevalence 
communities located further inland. We suggest that geographically targeted interventions that focus 
on high-prevalence FF populations should not restrict the roll-out of preventative measures in 
neighboring areas that could be sources of HIV-1 infection. Furthermore, this study supports calls to 
re-design prevention interventions to more effectively aid men of all ages to engage with and stay in 
care, and thereby reduce the disproportionate infection burden among women. Two-pronged 
intervention approaches that target both viral transmission sources to reduce transmission and sink 
populations to reduce risk of infection appear optimal in reducing the future HIV-1 incidence in key 
and general population groups. 
Supplementary Materials: The following are available online at www.mdpi.com, Figure S1: Markov Chain 
Monte Carlo (MCMC) simulation trajectories for estimated transmission flows within/between populations after 
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